Suppr超能文献

[粪便中活化原癌基因(Ki-ras)的测定。一种用于结直肠癌早期诊断的新实验室分析方法]

[Determination of the activated proto-oncogene (Ki-ras) in feces. A new laboratory analysis for early diagnosis of colorectal cancer].

作者信息

Koornstra J J, Røkke O, Halvorsen J F, Haug K, Ogreid D

机构信息

Senter for klinisk molekylaermedisin, Laboratorium for klinisk biokjemi, Haukeland Sykehus, Bergen.

出版信息

Tidsskr Nor Laegeforen. 1995 Oct 30;115(26):3266-70.

PMID:7482456
Abstract

Colorectal cancer is one of the most common malignancies in Norway. Many cases of the disease are detected at a stage where surgery is unlikely to result in cure. Currently used screening tests based on faecal occult blood and other tumour markers are poor indicators of colorectal neoplasia. Multiple gene alterations are associated with colorectal carcinogenesis. Mutations in the Ki-ras oncogene occur in 50% of colorectal carcinomas and also in 50% of the precursor lesions, the adenomas. These mutations have proved to be detectable in the faeces of patients with colorectal tumours, but the techniques used so far have been impractical for screening purposes. We have developed a rapid and simple laboratory technique, based on the polymerase chain reaction, for detecting mutated Ki-ras in the faeces. In eight of 12 patients with mutated Ki-ras in adenomas or carcinomas we found the corresponding mutations in stool samples. Our results represent a significant progression towards a simple and effective DNA-based screening strategy for early detection of curable colorectal cancer.

摘要

结直肠癌是挪威最常见的恶性肿瘤之一。该疾病的许多病例在手术不太可能治愈的阶段被发现。目前基于粪便潜血和其他肿瘤标志物的筛查测试对结直肠肿瘤的指示性较差。多种基因改变与结直肠癌发生相关。Ki-ras癌基因的突变发生在50%的结直肠癌中,也发生在50%的癌前病变即腺瘤中。已证明这些突变在结直肠肿瘤患者的粪便中可检测到,但迄今为止所使用的技术对于筛查目的而言并不实用。我们基于聚合酶链反应开发了一种快速且简单的实验室技术,用于检测粪便中突变的Ki-ras。在12例腺瘤或癌中存在Ki-ras突变的患者中,我们在8例患者的粪便样本中发现了相应的突变。我们的结果朝着一种用于早期检测可治愈性结直肠癌的简单有效的基于DNA的筛查策略迈出了重要进展。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验